Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Non-Hematologic Malignancy

Known as: Non-Hematologic Cancer, nonhematologic cancer 
Cancer that does not begin in the blood or bone marrow.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Importance Observational studies demonstrate links between patient-centered communication, quality of life (QOL), and aggressive… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2017
2017
Purpose To build on results of a cluster randomized controlled trial (RCT) of a combined patient-oncologist intervention to… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2014
2014
Circulating tumor cells (CTCs) are the principal vehicle for the spread of non-hematologic cancer disease from a primary tumor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Patients with chronic myeloproliferative neoplasms, including essential thrombocythemia (ET), polycythemia vera (PV), and chronic… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
To the authors' knowledge, the literature regarding extreme leukocytosis in solid tumor patients is sparse, consisting of a few… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND:  Red blood cell (RBC) alloimmunization is common in transfused patients. Most studies report on the rate of… Expand
Is this relevant?
2002
2002
Most hematogenous candidiasis originates from endogenous host flora. The impact of clinically prominent Candida colonization on… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Background Amphotericin B has long been the standard treatment for candidemia, but its use is complicated by its toxicity. More… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
BACKGROUND Amphotericin B has long been the standard treatment for candidemia, but its use is complicated by its toxicity. More… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Seventy-seven cytomegalovirus (CMV)-seronegative marrow transplant patients were randomized in a prospective controlled trial… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?